Document is current
Any future updates will be listed below
-
Authors
Cruz, Conrad Russell Y.
Bo, Na
Bakoyannis, Giorgos
Wright, Kaylor E.
Chorvinsky, Elizabeth A.
Powell, Allison
Bollard, Catherine M.
Jacobsohn, David
Cooke, Kenneth R.
Duncan, Christine
Krance, Robert M.
Carpenter, Paul A.
Rowan, Courtney M.
Paczesny, Sophie
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (5R01HD074587, 5R01HD074587, 5R01HD074587, 5R01HD074587, 5R01HD074587, 5R01HD074587, 5R01HD074587, 5R01HD074587, 5R01HD074587, 5R01HD074587, 5R01HD074587, 5R01HD074587, 5R01HD074587)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 23 April 2020
Revised: 23 June 2021
Accepted: 27 August 2021
First Online: 28 October 2021
Competing interests
: CRYC and CMB are co-founders of Mana Therapeutics, a biotech company developing T cell therapies for cancer. SP is an inventor on a patent on “Methods of detection of graft-versus-host disease” (US- 13/573,766). KRC is on the advisory board of Jazz pharmaceuticals. All other authors declare no competing interests
